The Federal government, on Sunday, has decided to produce PakVac on a large scale to overcome the scarcity of corona vaccine across the country.
The decision has been taken to initiate preparations for mass scale production of the single-dose PakVac from next month, sources said.
As per the sources, the National Institute of Health (NIH) Islamabad will prepare three million doses of PakVac monthly and the government has been informed about the decision.
The decision to produce vaccines on a large scale has been taken in view of the increased demand of the vaccine, sources said.
“Monthly production of three million vaccine doses will ensure sufficient availability of the corona vaccine jabs, which would significantly reduce the country’s dependence on other countries. The raw material of the vaccine will be provided by China’s Cansino Biologics,” sources said.
Pakistan has made a procurement deal with Cansino Bio for 20 million prepared doses and the raw material, according to sources.
Sinovac Vaccine: 1.55mn doses arrive in Pakistan
The government will buy more raw material from the Chinese vaccine company for preparation of PakVac, sources said.
Pakistan has earlier made bulk purchases over 27.5 million vaccine doses of China made vaccines including Sinopharm, Sinovac and CanSino vaccines.
According to the sources, “Under the procurement agreements raw material and prepared coronavirus vaccines will be purchased from the Chinese companies,”